Metagenics Nabs $28.1M

San Clemente-based Metagenics, a developer of nutraceuticals, has raised $28.1M in a funding, according to numbers in the Q3 PricewaterhouseCoopers/NVCA MoneyTree report. Source of the funding was not revealed, however, Amway announced in August that it would take a majority stake in Metagenics, via its Alticor Corporate Enterprises arm. Metagenics told Michigan's Grand Rapid Press at the time of the investment by Alticor that it had more than $200M in sales in 2008. A regulatory filing indicates the funding came on September 18th, and was for 1,878,255 shares of the firm's common stock.